about
Association of genetic polymorphisms with osteosarcoma risk: a meta-analysisA review of the association between osteosarcoma metastasis and protein translationTargeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsCTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519dNucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts.p21-activated kinase 7 is an oncogene in human osteosarcomaRPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis.Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma.Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.The prognostic significance of Src and p-Src expression in patients with osteosarcomaExpression of the immune regulation antigen CD70 in osteosarcoma.CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcomaGlobal gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways.Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesMitochondrial pathway and endoplasmic reticulum stress participate in the photosensitizing effectiveness of AE-PDT in MG63 cellsStructural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapyCCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cellsSynergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcomaProton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bedPreclinical validation of Aurora kinases-targeting drugs in osteosarcoma.Advances in emerging drugs for osteosarcoma.Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?Metastatic osteosarcoma: a challenging multidisciplinary treatment.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.The pharmacogenomics of osteosarcoma.Wogonoside induces cell cycle arrest and mitochondrial mediated apoptosis by modulation of Bcl-2 and Bax in osteosarcoma cancer cells.Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaInorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.PAK5 overexpression is associated with lung metastasis in osteosarcoma.The possible use of inorganic phosphate in osteosarcoma therapy.S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.The natural sweetener metabolite steviol inhibits the proliferation of human osteosarcoma U2OS cell line.
P2860
Q26797065-0D8ACFA5-2799-445F-B883-F996D175AD4DQ26825573-1948115E-422B-4ECC-B7BD-BB796FC231A9Q28554501-B9E5B2B2-D375-4572-A13C-452D697E2B1DQ33977066-3AA751DF-118C-4D6D-A113-926E104CBA2EQ33985880-73295111-BB3B-4FD1-8FF1-71E1789D4AECQ34024705-2B996A9B-BBE7-4F97-BB77-D33C30012B91Q34430382-435937FD-B2D1-4160-9DA1-A04FBB32CE46Q34436450-8EC43A41-9E52-40D6-825B-9BAD1487D726Q34991299-81FF1C38-F5EF-46FB-8BD5-6B54A2F6A7BAQ35085839-75959919-7CF5-4ACE-B17B-1542DD309D0FQ35161678-214D810A-E27D-43E9-90BA-BAE1E2484072Q35194116-788F0D7A-CE50-4ED2-BBB7-14AC06A0709AQ35746515-641B2F4A-9257-46FC-9D91-C63C8CE3B9BAQ35884951-269D10C8-08BF-4A1C-A02D-69962FA9D278Q35971858-6946BD10-4B96-4551-BC2F-E044273C1555Q35987375-764DABB2-27D0-4573-984D-E9ABB33A8114Q36152503-AC8CBCF5-B192-4B0B-BA1F-819250451EF8Q36674097-D2B1B7A7-FE1C-4FA6-A508-DF313882D323Q36782428-A4F2F756-A4CC-4B6F-8557-71ACD535106CQ36858560-F4178E64-4147-45F6-BE44-6261A7769BDEQ37067646-8E8650EC-F6AC-41C8-8162-FA7F9DC01C0EQ37273398-5756D09E-4A7A-4349-A1F0-15177FCDF5ECQ37323073-DE29328B-E179-4FAC-A57B-BD3FF316D438Q38506118-54E1A5AE-015A-4DB5-A6A7-DE7FFD60D88DQ38533459-BBD0222E-9CFE-4A8C-89BD-DE92B8706CA2Q38704293-AFEED52E-E04C-488F-A7C8-9F8D3032125DQ38759270-68135286-5489-47AD-9AD5-C35FE4B8E733Q38783252-2BFD6E2F-D0F0-4721-A77B-9C0D0CE24422Q38791215-20B1F2FD-262B-4A83-8AD2-8E632B7800D0Q38848413-BF2D1106-17D7-4A60-ABC6-D29A6BFA2371Q38901739-805797A0-1D6A-4D9F-8339-91BFA80018BBQ38959358-4EF99253-75F8-4512-8C86-9AB5ED8B07E3Q38981617-AA6AA72D-2FCB-44FB-BAC0-6E8368AC125EQ39159252-593CC24E-1EE7-4767-95FB-3DA8F043E46AQ39246205-46E375DD-3334-482D-8F97-79E53F5FCD92Q39335691-458F2385-B05E-40FF-8AC4-D134B7886B5CQ49422936-B50421B5-F955-4DBF-81DC-F1C89EF4AF63Q51440848-2A5678E2-EC32-4443-AAA2-0C246D05776BQ52605294-BD35C5BC-9706-4CA1-93A5-347EC76C0680Q52725867-848CA4D7-A2D0-4C12-B78B-8B0649436EC2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging drugs for high-grade osteosarcoma.
@en
Emerging drugs for high-grade osteosarcoma.
@nl
type
label
Emerging drugs for high-grade osteosarcoma.
@en
Emerging drugs for high-grade osteosarcoma.
@nl
prefLabel
Emerging drugs for high-grade osteosarcoma.
@en
Emerging drugs for high-grade osteosarcoma.
@nl
P2860
P50
P1476
Emerging drugs for high-grade osteosarcoma.
@en
P2093
Stefano Ferrari
P2860
P304
P356
10.1517/14728214.2010.505603
P407
P577
2010-08-09T00:00:00Z